# A Phase I Study on ReT01 ACT for the Treatment of Advanced Solid Tumors

> **NCT06257680** · PHASE1 · RECRUITING · sponsor: **Aeonvital Biomedicine** · enrollment: 15 (estimated)

## Conditions studied

- Advanced Solid Tumor

## Interventions

- **BIOLOGICAL:** ReT01 ACT

## Key facts

- **NCT ID:** NCT06257680
- **Lead sponsor:** Aeonvital Biomedicine
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-04-08
- **Primary completion:** 2025-02-18
- **Final completion:** 2027-02-18
- **Target enrollment:** 15 (ESTIMATED)
- **Last updated:** 2024-07-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06257680

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06257680, "A Phase I Study on ReT01 ACT for the Treatment of Advanced Solid Tumors". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06257680. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*